These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6166032

  • 1. [Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
    Romeo F, Spina A, Cannaò G.
    Recenti Prog Med; 1980 Dec; 69(6):577-643. PubMed ID: 6166032
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I, Porres Cubero JC, Carreño García V.
    Rev Clin Esp; 1984 Apr 15; 173(1):9-14. PubMed ID: 6330799
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
    Bonino F, 'Hepatitis B virus heterogeneity--a means to personalized care' steering committee.
    Antivir Ther; 2010 Apr 15; 15 Suppl 3():1-2. PubMed ID: 21041898
    [No Abstract] [Full Text] [Related]

  • 9. Approaches to the treatment of chronic hepatitis B viral infection.
    Thomas HC, Lok AS.
    Prog Clin Biol Res; 1983 Apr 15; 143():379-93. PubMed ID: 6199798
    [Abstract] [Full Text] [Related]

  • 10. [Hepatitis B virus infection in the absence of serological markers or with atypical serological patterns].
    Moreno García M.
    Rev Clin Esp; 1997 Apr 15; 197(4):248-58. PubMed ID: 9254401
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy of chronic hepatitis (author's transl)].
    Auer IO.
    Leber Magen Darm; 1980 Oct 15; 10(5):251-8. PubMed ID: 6162069
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B viral infections: clinical, pathological, serological features and treatment.
    Lane MR, Lee SP, Yeong ML, Woodfield DG.
    N Z Med J; 1985 Feb 13; 98(772):57-61. PubMed ID: 2983271
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G.
    Ital J Gastroenterol; 1996 Feb 13; 28(6):324-31. PubMed ID: 8891847
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Hepatitis B virus infection: current developments].
    van Ditzhuysen JM, van Loon AM, Yap SH.
    Ned Tijdschr Geneeskd; 1983 Nov 26; 127(48):2193-8. PubMed ID: 6318129
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic hepatitis B].
    Carreño V, Montaño L, Torres M.
    Rev Clin Esp; 1983 Oct 15; 171(1):73-6. PubMed ID: 6197728
    [No Abstract] [Full Text] [Related]

  • 18. [Immune lesion of hepatitis B].
    García Buey L, González Mateos F, García Monzón C, Moreno Otero R.
    Gastroenterol Hepatol; 2001 Feb 15; 24 Suppl 1():15-28. PubMed ID: 11279891
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R, Rabagliati AM.
    G Batteriol Virol Immunol; 1981 Feb 15; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.